STAT+: Hims takes a $33 million hit from GLP-1 ‘pivot’

In this edition of STAT Health Tech: Hims earnings, Omada's PBM strategy, and the uphill battle faced by new sepsis algorithms.
Source
Stat News
Opens original article in a new tab
AI Bias Analysis
4 models · Takes ~15 seconds

In this edition of STAT Health Tech: Hims earnings, Omada's PBM strategy, and the uphill battle faced by new sepsis algorithms.
Source
Stat News
Opens original article in a new tab

The deadliest drug in the country, the new name for PCOS, and more health news from Morning Rounds

Bristol's partnership with Hengrui Pharma, Viiv loses HIV treatment case, and more biotech news from The Readout

STAT examines America's failure to address excessive alcohol use across decades.

(MedPage Today) -- Note that some links may require registration or subscription. Spring & Mulberry expanded its voluntary recall of select chocolate bars because of possible Salmonella risk, the FDA posted. While HHS Secretary Robert F...